# Evaluating the Impact of Baduanjin Exercise Intervention on Quality of Life in Breast Cancer Survivors Receiving Aromatase Inhibitor Therapy

> **NCT03162133** · NA · COMPLETED · sponsor: **Guangdong Provincial People's Hospital** · enrollment: 86 (actual)

## Conditions studied

- Breast Cancer Survivors Receiving Aromatase Inhibitor Therapy

## Interventions

- **OTHER:** Baduanjin exercise

## Key facts

- **NCT ID:** NCT03162133
- **Lead sponsor:** Guangdong Provincial People's Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-11-10
- **Primary completion:** 2017-11-10
- **Final completion:** 2018-11-10
- **Target enrollment:** 86 (ACTUAL)
- **Last updated:** 2020-07-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03162133

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03162133, "Evaluating the Impact of Baduanjin Exercise Intervention on Quality of Life in Breast Cancer Survivors Receiving Aromatase Inhibitor Therapy". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03162133. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*